General Information
Revision date
2021-10-19
Product name
NIMBEX SOLUTION
Product Synonyms
CISATRAC * CISATRAC FORTE * NIMBEX SOLUTION FOR INJECTION/INFUSION (2 MG/ML, 5 MG/ML,10 MG/ML) * NIMBEX 5 * NIMBEX FORTE * NIMBEX FORTE SOLUTION FOR
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Health hazards
Skin corrosion/irritation Category 2 H315 - Causes skin irritation. Serious eye damage/eye irritation Category 1 H318 - Causes serious eye damage. Hazard summary Caution - Pharmaceutical agent. Causes serious eye damage. Causes skin irritation. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
Benzenesulfonic acid, CIS-ATRACURIUM BESYLATE
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H318 Causes serious eye damage.
Prevention
P264 Wash hands thoroughly after handling. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTRE/doctor/. P332 + P313 If skin irritation occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
2.25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2.25 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 1.2 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
